I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
2 Ergebnisse
1
Cost-utility analysis of biologic disease-modifying antirhe..:
Juthamas Prawjaeng
;
Pattara Leelahavarong
;
Nuttakarn Budtarad
...
https://doi.org/10.1186/s12913-023-09595-1. , 2023
Link:
https://doi.org/10.1186/s12913-023-09595-1
2
Cost-utility analysis of biologic disease-modifying antirhe..:
Juthamas Prawjaeng
;
Pattara Leelahavarong
;
Nuttakarn Budtarad
...
https://doi.org/10.1186/s12913-023-09595-1. , 2023
Link:
https://doi.org/10.1186/s12913-023-09595-1
RT Journal T1
Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:468a5c7f637b40ca804a284ffe446d81&Exemplar=1&LAN=DE A1 Juthamas Prawjaeng A1 Pattara Leelahavarong A1 Nuttakarn Budtarad A1 Songyot Pilasant A1 Chonticha Chanjam A1 Wanruchada Katchamart A1 Pongthorn Narongroeknawin A1 Tasanee Kitumnuaypong PB BMC YR 2023 K1 Economic evaluation K1 Cost-utility analysis K1 Disease-modifying antirheumatic drugs K1 Biologic DMARDs K1 Targeted synthetic DMARDs K1 Biosimilar DMARDs K1 Public aspects of medicine K1 RA1-1270 JF https://doi.org/10.1186/s12913-023-09595-1 LK http://dx.doi.org/https://doi.org/10.1186/s12913-023-09595-1 DO https://doi.org/10.1186/s12913-023-09595-1 SF ELIB - SuUB Bremen RT Journal T1
Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:468a5c7f637b40ca804a284ffe446d81&Exemplar=1&LAN=DE A1 Juthamas Prawjaeng A1 Pattara Leelahavarong A1 Nuttakarn Budtarad A1 Songyot Pilasant A1 Chonticha Chanjam A1 Wanruchada Katchamart A1 Pongthorn Narongroeknawin A1 Tasanee Kitumnuaypong PB BMC YR 2023 K1 Economic evaluation K1 Cost-utility analysis K1 Disease-modifying antirheumatic drugs K1 Biologic DMARDs K1 Targeted synthetic DMARDs K1 Biosimilar DMARDs K1 Public aspects of medicine K1 RA1-1270 JF https://doi.org/10.1186/s12913-023-09595-1 LK http://dx.doi.org/https://doi.org/10.1186/s12913-023-09595-1 DO https://doi.org/10.1186/s12913-023-09595-1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)